Richard Jaenisch explains what FDA's real-world use case database means for CMC and quality teams navigating NAMs.
|Articles|March 2, 2019
Stevanato Group Engineering Systems
Stevanato Group Engineering Systems Division is a leading supplier of complete solutions from handling through visual inspection, assembling, and serialization up to final packaging.
Stevanato Group Engineering Systems Division is a leading supplier of complete solutions from handling through visual inspection, assembling, and serialization up to final packaging. It is the ideal partner for any pharmaceutical and healthcare company seeking proven and reliable technology customized to its specific needs.
Via Molinella, 17 – 35017 Piombino Dese (PD) – Italy
tel. 0039 049 9318111
engineering@stevanatogroup.com
INTERPHEX Booth Number: 3202
Related to this article
Boyang Wang, Immortal Dragons, explains how FDA’s Expedited IND Pilot and research partners could speed serial steps to first-in-human trials compared to China’s 818 Decree.
This article examines how modern automation platforms create the digital foundation required for Pharma 4.0 by integrating manufacturing systems, centralized data management, Industrial Internet of Things connectivity, electronic batch production records, and AI-driven analytics.
PharmTech AI Pulse Check panelists explain why attribution, audit trails, and sign-off matter more than AI watermark detection for GxP quality teams.
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Trending on Pharmaceutical Technology
1
Q&A: Patient-Centric Drug Development Should Start at Product Definition
2
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
3
PharmTech AI Pulse Check: AI Watermark Vulnerability
4
Clinical Trial Delays: FDA’s Expedited IND Pilot vs China’s 818 Decree
5